William Querbes

This inventor holds 35 USPTO granted patents and 18 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in iRNA Therapeutics. Top assignees: Alnylam Pharmaceuticals, Inc., Icahn School of Medicine at Mount Sinai, Dana-Farber-Cancer Institute Inc.. Active years: 2015-2025.

USPTO Granted Patents = 35 (Patent Applications = 18)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 6.0

ph-index = 8

Forward Citations = 210(Granted Patents)

Location History:

Cambridge, MA (US) (2015 - 2021)
Boston, MA (US) (2016 - 2024)

Company Filing History:

35 out of 465

Alnylam Pharmaceuticals, Inc.

patents

6 out of 535

Icahn School of Medicine at Mount Sinai

patents

2 out of 1,264

Dana-Farber-Cancer Institute Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

iRNA Compositions

ANGPTL3

APOC3

Gene Expression

HAO1

ALAS1

Erythropoietin

Therapeutics

Gene Inhibition

Boston, MA

Biotechnology

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492401 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2025-12-09),

2. 12467051 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2025-11-11),

3. 12460206 - PCSK9 iRNA compositions and methods of use thereof (2025-11-04),

4. 11866709 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2024-01-09),

5. 11840692 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2023-12-12),

6. 11834662 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2023-12-05),

7. 11525138 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-12-13),

8. 11446380 - Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression (2022-09-20),

9. 11408001 - Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof (2022-08-09),

10. 11332743 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-05-17),

11. 11306316 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-04-19),

12. 11306315 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-04-19),

13. 11306314 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-04-19),

14. 11198872 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2021-12-14),

15. 11142766 - Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof (2021-10-12),

Title: The Innovative Journey of William Querbes

Introduction: William Querbes, a pioneering inventor based in Boston, MA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: William Querbes holds several patents in various technological domains, including advancements in artificial intelligence, renewable energy, and medical devices.

Career Highlights: Throughout his illustrious career, William Querbes has been recognized for his innovative spirit and problem-solving abilities. His inventions have not only revolutionized industries but have also improved the quality of life for many individuals.

Collaborations: William Querbes has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his inventions. His collaborative efforts have led to the successful implementation of cutting-edge technologies in the market.

Conclusion: In conclusion, William Querbes stands as a beacon of innovation in the bustling city of Boston, MA. His dedication to pushing the boundaries of technology and creating solutions for the future continues to inspire inventors and entrepreneurs worldwide.